Antony Pfaffle, Interim Chief Medical Officer at CorMedix Inc. (CRMD), sold 40,000 shares at $2.58 ($105K) on 2016-05-13, disclosed to the SEC on 2016-05-17.
Open-market sale of $105k CRMD by Interim Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.58 | 20,000 | $52K | 49.0% |
| 2 | $2.68 | 20,000 | $54K | 51.0% |
| Total | $2.63 avg | 40,000 | $105K | 100% |
| Filing → |
| CRMD | SELL | 2016-06-22 | $127K | — | Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |